Therapeutic CCR2 Blockade Prevents Inflammation and Alleviates Myxomatous Valve Disease in Marfan Syndrome
Summary: Myxomatous valve disease (MVD) can lead to cardiac umpqua u series hooks dysfunction and heart failure, yet medical therapies are lacking.C-C chemokine receptor type 2 (CCR2)+ immune cell infiltration promotes mitral valve inflammation in a Marfan syndrome (MFS) mouse model.The CCR2 genetic knockout reduces inflammation with downregulated